Jennifer M Doughty

Title: **Jennifer M Doughty: Innovator in Neuropathic Pain and Cancer Treatment**

Introduction

Jennifer M Doughty is a prominent inventor based in Portland, ME, known for her innovative contributions to the field of medicine. With a focus on addressing critical health issues, she has made significant strides in developing treatments for neuropathic pain and colon cancer through her groundbreaking research.

Latest Patents

Doughty holds a patent titled "Use of EP4 receptor ligands in the treatment of neuropathic pain and colon cancer." This invention relates to the application of an EP4 receptor ligand in the manufacturing of a medicament aimed at treating neuropathic pain, colon cancer, migraines, and increasing the latency of HIV infection. This patent underscores her commitment to enhancing therapeutic options for patients suffering from these serious health conditions.

Career Highlights

Doughty is employed at SmithKline Beecham Corporation, where she has the opportunity to apply her expertise in pharmacology and drug development. Her work at this esteemed organization has been instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Throughout her career, Jennifer Doughty has collaborated with notable colleagues, including Nicholas Maughan Clayton and Susanne Denise Collins. These partnerships reflect her ability to work effectively in a team-oriented environment, fostering innovation and driving progress in her field.

Conclusion

Jennifer M Doughty's dedication to innovation and her significant contributions to medical research highlight her role as an influential inventor. With her patented work on EP4 receptor ligands, she stands at the forefront of developing new approaches to treating debilitating health issues, making a lasting impact on the medical community and patients alike.